Recombinant Human Osteoprotegerin (OPG)
£454.69
Recombinant Human Osteoprotegerin (OPG) (O102-25ug)
Product
| Cat # O102-25ug | Size 25 µg |
Price
£454.69
|
Qty
|
Description
Osteoprotegerin (OPG), also known as TNFRSF11B, is a cytokine and member of the TNF receptor superfamily that is expressed in a wide variety of tissues including adult heart, lung, kidney, liver, spleen, prostate, lymph node and bone marrow. OPG is an osteoblast-secreted decoy receptor that functions as a negative regulator of bone resorption.1 It specifically binds to its ligand, osteoprotegerin ligand (OPGL), which is a key extracellular regulator of osteoclast development. Therefore, OPG may provide a pharmacological tool for osteoporotic and erosive bone disorders.
Specifications
| Manufacturer | Leinco Technologies Inc |
|---|---|
| Manufacturer Cat# | O102 |
| Product Size | 25 µg |
| Formulation | This recombinant protein was 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives. |
| Alternate Names | Osteoprotegerin Recombinant Human Osteoprotegerin OPG Recombinant Human Osteoprotegerin TNFRSF11B Osteoclast Inhibitory Factor OCIF MGC29565 TR1 OCIT Recombinant Human Osteoprotegerin Recombinant Protein Osteoprotegerin TNFRSF11B Osteoclast Inhibitory Factor OCIF MGC29565 TR1 OCIT OPG Human Osteoprotegerin Recombinant Human Osteoprotegerin Recombinant Human Osteoprotegerin |
| Target | Osteoprotegerin |
| Storage | -20°C to -70°C |
| Protein | Osteoprotegerin |